Transforming Growth Factor Beta 1 Industry Research Report 2023

Transforming Growth Factor Beta 1 Industry Research Report 2023


Transforming growth factor beta 1 or TGF-β1 is a polypeptide member of the transforming growth factor beta superfamily of cytokines. It is a secreted protein that performs many cellular functions, including the control of cell growth, cell proliferation, cell differentiation, and apoptosis. In humans, TGF-β1 is encoded by the TGFB1 gene

Highlights

The global Transforming Growth Factor Beta 1 market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
North America is the largest Transforming Growth Factor Beta 1 market with about 69% market share. Europe is follower, accounting for about 16% market share.The key manufacturers are Roche, Shionogi Ltd, Acceleron Pharma Inc, Genzyme Corp, Isarna Therapeutics GmbH, Scholar Rock, Sirnaomics Inc, Eli Lilly and Co, Formation Biologics Inc, Novartis AG etc.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Transforming Growth Factor Beta 1, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transforming Growth Factor Beta 1.
The Transforming Growth Factor Beta 1 market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Transforming Growth Factor Beta 1 market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Transforming Growth Factor Beta 1 manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights


In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2018-2023. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Roche
Shionogi Ltd
Acceleron Pharma Inc
Genzyme Corp
Isarna Therapeutics GmbH
Scholar Rock
Sirnaomics Inc
Eli Lilly and Co
Formation Biologics Inc
Novartis AG

Product Type Insights

Global markets are presented by Transforming Growth Factor Beta 1 type, along with growth forecasts through 2029. Estimates on sales and revenue are based on the price in the supply chain at which the Transforming Growth Factor Beta 1 are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Transforming Growth Factor Beta 1 segment by Type

Pirfenidone
Galunisertib
Others

Application Insights

This report has provided the market size (sales and revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Transforming Growth Factor Beta 1 market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Transforming Growth Factor Beta 1 market.
Transforming Growth Factor Beta 1 segment by Application

IPF
Cancer
Others

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2023 and forecast revenue for 2029.

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Transforming Growth Factor Beta 1 market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transforming Growth Factor Beta 1 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Transforming Growth Factor Beta 1 and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Transforming Growth Factor Beta 1 industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transforming Growth Factor Beta 1.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Transforming Growth Factor Beta 1 manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Transforming Growth Factor Beta 1 by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Transforming Growth Factor Beta 1 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.

Frequently Asked Questions

Which product segment grabbed the largest share in the Product Name market?
How is the competitive scenario of the Product Name market?
Which are the key factors aiding the Product Name market growth?
Which are the prominent players in the Product Name market?
Which region holds the maximum share in the Product Name market?
What will be the CAGR of the Product Name market during the forecast period?
Which application segment emerged as the leading segment in the Product Name market?
What key trends are likely to emerge in the Product Name market in the coming years?
What will be the Product Name market size by 2028?
Which company held the largest share in the Product Name market?


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Transforming Growth Factor Beta 1 Market Size (2018-2029) & (US$ Million)
2.2.2 Global Transforming Growth Factor Beta 1 Sales (2018-2029)
2.2.3 Global Transforming Growth Factor Beta 1 Market Average Price (2018-2029)
2.3 Transforming Growth Factor Beta 1 by Type
2.3.1 Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
1.2.2 Pirfenidone
1.2.3 Galunisertib
1.2.4 Others
2.4 Transforming Growth Factor Beta 1 by Application
2.4.1 Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
2.4.2 IPF
2.4.3 Cancer
2.4.4 Others
3 Market Competitive Landscape by Manufacturers
3.1 Global Transforming Growth Factor Beta 1 Market Competitive Situation by Manufacturers (2018 Versus 2022)
3.2 Global Transforming Growth Factor Beta 1 Sales (K Units) of Manufacturers (2018-2023)
3.3 Global Transforming Growth Factor Beta 1 Revenue of Manufacturers (2018-2023)
3.4 Global Transforming Growth Factor Beta 1 Average Price by Manufacturers (2018-2023)
3.5 Global Transforming Growth Factor Beta 1 Industry Ranking, 2021 VS 2022 VS 2023
3.6 Global Manufacturers of Transforming Growth Factor Beta 1, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Transforming Growth Factor Beta 1, Product Type & Application
3.8 Global Manufacturers of Transforming Growth Factor Beta 1, Date of Enter into This Industry
3.9 Global Transforming Growth Factor Beta 1 Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Roche
4.1.1 Roche Company Information
4.1.2 Roche Business Overview
4.1.3 Roche Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2018-2023)
4.1.4 Roche Transforming Growth Factor Beta 1 Product Portfolio
4.1.5 Roche Recent Developments
4.2 Shionogi Ltd
4.2.1 Shionogi Ltd Company Information
4.2.2 Shionogi Ltd Business Overview
4.2.3 Shionogi Ltd Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2018-2023)
4.2.4 Shionogi Ltd Transforming Growth Factor Beta 1 Product Portfolio
4.2.5 Shionogi Ltd Recent Developments
4.3 Acceleron Pharma Inc
4.3.1 Acceleron Pharma Inc Company Information
4.3.2 Acceleron Pharma Inc Business Overview
4.3.3 Acceleron Pharma Inc Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2018-2023)
4.3.4 Acceleron Pharma Inc Transforming Growth Factor Beta 1 Product Portfolio
4.3.5 Acceleron Pharma Inc Recent Developments
4.4 Genzyme Corp
4.4.1 Genzyme Corp Company Information
4.4.2 Genzyme Corp Business Overview
4.4.3 Genzyme Corp Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2018-2023)
4.4.4 Genzyme Corp Transforming Growth Factor Beta 1 Product Portfolio
4.4.5 Genzyme Corp Recent Developments
4.5 Isarna Therapeutics GmbH
4.5.1 Isarna Therapeutics GmbH Company Information
4.5.2 Isarna Therapeutics GmbH Business Overview
4.5.3 Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Product Portfolio
6.5.5 Isarna Therapeutics GmbH Recent Developments
4.6 Scholar Rock
4.6.1 Scholar Rock Company Information
4.6.2 Scholar Rock Business Overview
4.6.3 Scholar Rock Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2018-2023)
4.6.4 Scholar Rock Transforming Growth Factor Beta 1 Product Portfolio
4.6.5 Scholar Rock Recent Developments
4.7 Sirnaomics Inc
4.7.1 Sirnaomics Inc Company Information
4.7.2 Sirnaomics Inc Business Overview
4.7.3 Sirnaomics Inc Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2018-2023)
4.7.4 Sirnaomics Inc Transforming Growth Factor Beta 1 Product Portfolio
4.7.5 Sirnaomics Inc Recent Developments
6.8 Eli Lilly and Co
4.8.1 Eli Lilly and Co Company Information
4.8.2 Eli Lilly and Co Business Overview
4.8.3 Eli Lilly and Co Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2018-2023)
4.8.4 Eli Lilly and Co Transforming Growth Factor Beta 1 Product Portfolio
4.8.5 Eli Lilly and Co Recent Developments
4.9 Formation Biologics Inc
4.9.1 Formation Biologics Inc Company Information
4.9.2 Formation Biologics Inc Business Overview
4.9.3 Formation Biologics Inc Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2018-2023)
4.9.4 Formation Biologics Inc Transforming Growth Factor Beta 1 Product Portfolio
4.9.5 Formation Biologics Inc Recent Developments
4.10 Novartis AG
4.10.1 Novartis AG Company Information
4.10.2 Novartis AG Business Overview
4.10.3 Novartis AG Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2018-2023)
4.10.4 Novartis AG Transforming Growth Factor Beta 1 Product Portfolio
4.10.5 Novartis AG Recent Developments
5 Global Transforming Growth Factor Beta 1 Market Scenario by Region
5.1 Global Transforming Growth Factor Beta 1 Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Transforming Growth Factor Beta 1 Sales by Region: 2018-2029
5.2.1 Global Transforming Growth Factor Beta 1 Sales by Region: 2018-2023
5.2.2 Global Transforming Growth Factor Beta 1 Sales by Region: 2024-2029
5.3 Global Transforming Growth Factor Beta 1 Revenue by Region: 2018-2029
5.3.1 Global Transforming Growth Factor Beta 1 Revenue by Region: 2018-2023
5.3.2 Global Transforming Growth Factor Beta 1 Revenue by Region: 2024-2029
5.4 North America Transforming Growth Factor Beta 1 Market Facts & Figures by Country
5.4.1 North America Transforming Growth Factor Beta 1 Market Size by Country: 2018 VS 2022 VS 2029
5.4.2 North America Transforming Growth Factor Beta 1 Sales by Country (2018-2029)
5.4.3 North America Transforming Growth Factor Beta 1 Revenue by Country (2018-2029)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Transforming Growth Factor Beta 1 Market Facts & Figures by Country
5.5.1 Europe Transforming Growth Factor Beta 1 Market Size by Country: 2018 VS 2022 VS 2029
5.5.2 Europe Transforming Growth Factor Beta 1 Sales by Country (2018-2029)
5.5.3 Europe Transforming Growth Factor Beta 1 Revenue by Country (2018-2029)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Transforming Growth Factor Beta 1 Market Facts & Figures by Country
5.6.1 Asia Pacific Transforming Growth Factor Beta 1 Market Size by Country: 2018 VS 2022 VS 2029
5.6.2 Asia Pacific Transforming Growth Factor Beta 1 Sales by Country (2018-2029)
5.6.3 Asia Pacific Transforming Growth Factor Beta 1 Revenue by Country (2018-2029)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Transforming Growth Factor Beta 1 Market Facts & Figures by Country
5.7.1 Latin America Transforming Growth Factor Beta 1 Market Size by Country: 2018 VS 2022 VS 2029
5.7.2 Latin America Transforming Growth Factor Beta 1 Sales by Country (2018-2029)
5.7.3 Latin America Transforming Growth Factor Beta 1 Revenue by Country (2018-2029)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Transforming Growth Factor Beta 1 Market Facts & Figures by Country
5.8.1 Middle East and Africa Transforming Growth Factor Beta 1 Market Size by Country: 2018 VS 2022 VS 2029
5.8.2 Middle East and Africa Transforming Growth Factor Beta 1 Sales by Country (2018-2029)
5.8.3 Middle East and Africa Transforming Growth Factor Beta 1 Revenue by Country (2018-2029)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global Transforming Growth Factor Beta 1 Sales by Type (2018-2029)
6.1.1 Global Transforming Growth Factor Beta 1 Sales by Type (2018-2029) & (K Units)
6.1.2 Global Transforming Growth Factor Beta 1 Sales Market Share by Type (2018-2029)
6.2 Global Transforming Growth Factor Beta 1 Revenue by Type (2018-2029)
6.2.1 Global Transforming Growth Factor Beta 1 Sales by Type (2018-2029) & (US$ Million)
6.2.2 Global Transforming Growth Factor Beta 1 Revenue Market Share by Type (2018-2029)
6.3 Global Transforming Growth Factor Beta 1 Price by Type (2018-2029)
7 Segment by Application
7.1 Global Transforming Growth Factor Beta 1 Sales by Application (2018-2029)
7.1.1 Global Transforming Growth Factor Beta 1 Sales by Application (2018-2029) & (K Units)
7.1.2 Global Transforming Growth Factor Beta 1 Sales Market Share by Application (2018-2029)
7.2 Global Transforming Growth Factor Beta 1 Revenue by Application (2018-2029)
6.2.1 Global Transforming Growth Factor Beta 1 Sales by Application (2018-2029) & (US$ Million)
6.2.2 Global Transforming Growth Factor Beta 1 Revenue Market Share by Application (2018-2029)
7.3 Global Transforming Growth Factor Beta 1 Price by Application (2018-2029)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Transforming Growth Factor Beta 1 Value Chain Analysis
8.1.1 Transforming Growth Factor Beta 1 Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Transforming Growth Factor Beta 1 Production Mode & Process
8.2 Transforming Growth Factor Beta 1 Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Transforming Growth Factor Beta 1 Distributors
8.2.3 Transforming Growth Factor Beta 1 Customers
9 Global Transforming Growth Factor Beta 1 Analyzing Market Dynamics
9.1 Transforming Growth Factor Beta 1 Industry Trends
9.2 Transforming Growth Factor Beta 1 Industry Drivers
9.3 Transforming Growth Factor Beta 1 Industry Opportunities and Challenges
9.4 Transforming Growth Factor Beta 1 Industry Restraints
10 Report Conclusion
11 Disclaimer
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Transforming Growth Factor Beta 1 Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global Transforming Growth Factor Beta 1 Sales (K Units) of Manufacturers (2018-2023)
Table 7. Global Transforming Growth Factor Beta 1 Sales Market Share by Manufacturers (2018-2023)
Table 8. Global Transforming Growth Factor Beta 1 Revenue of Manufacturers (2018-2023)
Table 9. Global Transforming Growth Factor Beta 1 Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market Transforming Growth Factor Beta 1 Average Price (USD/Unit) of Manufacturers (2018-2023)
Table 11. Global Transforming Growth Factor Beta 1 Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of Transforming Growth Factor Beta 1, Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Transforming Growth Factor Beta 1 by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. Roche Company Information
Table 17. Roche Business Overview
Table 18. Roche Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 19. Roche Transforming Growth Factor Beta 1 Product Portfolio
Table 20. Roche Recent Developments
Table 21. Shionogi Ltd Company Information
Table 22. Shionogi Ltd Business Overview
Table 23. Shionogi Ltd Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 24. Shionogi Ltd Transforming Growth Factor Beta 1 Product Portfolio
Table 25. Shionogi Ltd Recent Developments
Table 26. Acceleron Pharma Inc Company Information
Table 27. Acceleron Pharma Inc Business Overview
Table 28. Acceleron Pharma Inc Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 29. Acceleron Pharma Inc Transforming Growth Factor Beta 1 Product Portfolio
Table 30. Acceleron Pharma Inc Recent Developments
Table 31. Genzyme Corp Company Information
Table 32. Genzyme Corp Business Overview
Table 33. Genzyme Corp Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 34. Genzyme Corp Transforming Growth Factor Beta 1 Product Portfolio
Table 35. Genzyme Corp Recent Developments
Table 36. Isarna Therapeutics GmbH Company Information
Table 37. Isarna Therapeutics GmbH Business Overview
Table 38. Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 39. Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Product Portfolio
Table 40. Isarna Therapeutics GmbH Recent Developments
Table 41. Scholar Rock Company Information
Table 42. Scholar Rock Business Overview
Table 43. Scholar Rock Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 44. Scholar Rock Transforming Growth Factor Beta 1 Product Portfolio
Table 45. Scholar Rock Recent Developments
Table 46. Sirnaomics Inc Company Information
Table 47. Sirnaomics Inc Business Overview
Table 48. Sirnaomics Inc Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 49. Sirnaomics Inc Transforming Growth Factor Beta 1 Product Portfolio
Table 50. Sirnaomics Inc Recent Developments
Table 51. Eli Lilly and Co Company Information
Table 52. Eli Lilly and Co Business Overview
Table 53. Eli Lilly and Co Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 54. Eli Lilly and Co Transforming Growth Factor Beta 1 Product Portfolio
Table 55. Eli Lilly and Co Recent Developments
Table 56. Formation Biologics Inc Company Information
Table 57. Formation Biologics Inc Business Overview
Table 58. Formation Biologics Inc Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 59. Formation Biologics Inc Transforming Growth Factor Beta 1 Product Portfolio
Table 60. Formation Biologics Inc Recent Developments
Table 61. Novartis AG Company Information
Table 62. Novartis AG Business Overview
Table 63. Novartis AG Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 64. Novartis AG Transforming Growth Factor Beta 1 Product Portfolio
Table 65. Novartis AG Recent Developments
Table 66. Global Transforming Growth Factor Beta 1 Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 67. Global Transforming Growth Factor Beta 1 Sales by Region (2018-2023) & (K Units)
Table 68. Global Transforming Growth Factor Beta 1 Sales Market Share by Region (2018-2023)
Table 69. Global Transforming Growth Factor Beta 1 Sales by Region (2024-2029) & (K Units)
Table 70. Global Transforming Growth Factor Beta 1 Sales Market Share by Region (2024-2029)
Table 71. Global Transforming Growth Factor Beta 1 Revenue by Region (2018-2023) & (US$ Million)
Table 72. Global Transforming Growth Factor Beta 1 Revenue Market Share by Region (2018-2023)
Table 73. Global Transforming Growth Factor Beta 1 Revenue by Region (2024-2029) & (US$ Million)
Table 74. Global Transforming Growth Factor Beta 1 Revenue Market Share by Region (2024-2029)
Table 75. North America Transforming Growth Factor Beta 1 Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 76. North America Transforming Growth Factor Beta 1 Sales by Country (2018-2023) & (K Units)
Table 77. North America Transforming Growth Factor Beta 1 Sales by Country (2024-2029) & (K Units)
Table 78. North America Transforming Growth Factor Beta 1 Revenue by Country (2018-2023) & (US$ Million)
Table 79. North America Transforming Growth Factor Beta 1 Revenue by Country (2024-2029) & (US$ Million)
Table 80. Europe Transforming Growth Factor Beta 1 Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 81. Europe Transforming Growth Factor Beta 1 Sales by Country (2018-2023) & (K Units)
Table 82. Europe Transforming Growth Factor Beta 1 Sales by Country (2024-2029) & (K Units)
Table 83. Europe Transforming Growth Factor Beta 1 Revenue by Country (2018-2023) & (US$ Million)
Table 84. Europe Transforming Growth Factor Beta 1 Revenue by Country (2024-2029) & (US$ Million)
Table 85. Asia Pacific Transforming Growth Factor Beta 1 Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 86. Asia Pacific Transforming Growth Factor Beta 1 Sales by Country (2018-2023) & (K Units)
Table 87. Asia Pacific Transforming Growth Factor Beta 1 Sales by Country (2024-2029) & (K Units)
Table 88. Asia Pacific Transforming Growth Factor Beta 1 Revenue by Country (2018-2023) & (US$ Million)
Table 89. Asia Pacific Transforming Growth Factor Beta 1 Revenue by Country (2024-2029) & (US$ Million)
Table 90. Latin America Transforming Growth Factor Beta 1 Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Latin America Transforming Growth Factor Beta 1 Sales by Country (2018-2023) & (K Units)
Table 92. Latin America Transforming Growth Factor Beta 1 Sales by Country (2024-2029) & (K Units)
Table 93. Latin America Transforming Growth Factor Beta 1 Revenue by Country (2018-2023) & (US$ Million)
Table 94. Latin America Transforming Growth Factor Beta 1 Revenue by Country (2024-2029) & (US$ Million)
Table 95. Middle East and Africa Transforming Growth Factor Beta 1 Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 96. Middle East and Africa Transforming Growth Factor Beta 1 Sales by Country (2018-2023) & (K Units)
Table 97. Middle East and Africa Transforming Growth Factor Beta 1 Sales by Country (2024-2029) & (K Units)
Table 98. Middle East and Africa Transforming Growth Factor Beta 1 Revenue by Country (2018-2023) & (US$ Million)
Table 99. Middle East and Africa Transforming Growth Factor Beta 1 Revenue by Country (2024-2029) & (US$ Million)
Table 100. Global Transforming Growth Factor Beta 1 Sales by Type (2018-2023) & (K Units)
Table 101. Global Transforming Growth Factor Beta 1 Sales by Type (2024-2029) & (K Units)
Table 102. Global Transforming Growth Factor Beta 1 Sales Market Share by Type (2018-2023)
Table 103. Global Transforming Growth Factor Beta 1 Sales Market Share by Type (2024-2029)
Table 104. Global Transforming Growth Factor Beta 1 Revenue by Type (2018-2023) & (US$ Million)
Table 105. Global Transforming Growth Factor Beta 1 Revenue by Type (2024-2029) & (US$ Million)
Table 106. Global Transforming Growth Factor Beta 1 Revenue Market Share by Type (2018-2023)
Table 107. Global Transforming Growth Factor Beta 1 Revenue Market Share by Type (2024-2029)
Table 108. Global Transforming Growth Factor Beta 1 Price by Type (2018-2023) & (USD/Unit)
Table 109. Global Transforming Growth Factor Beta 1 Price by Type (2024-2029) & (USD/Unit)
Table 110. Global Transforming Growth Factor Beta 1 Sales by Application (2018-2023) & (K Units)
Table 111. Global Transforming Growth Factor Beta 1 Sales by Application (2024-2029) & (K Units)
Table 112. Global Transforming Growth Factor Beta 1 Sales Market Share by Application (2018-2023)
Table 113. Global Transforming Growth Factor Beta 1 Sales Market Share by Application (2024-2029)
Table 114. Global Transforming Growth Factor Beta 1 Revenue by Application (2018-2023) & (US$ Million)
Table 115. Global Transforming Growth Factor Beta 1 Revenue by Application (2024-2029) & (US$ Million)
Table 116. Global Transforming Growth Factor Beta 1 Revenue Market Share by Application (2018-2023)
Table 117. Global Transforming Growth Factor Beta 1 Revenue Market Share by Application (2024-2029)
Table 118. Global Transforming Growth Factor Beta 1 Price by Application (2018-2023) & (USD/Unit)
Table 119. Global Transforming Growth Factor Beta 1 Price by Application (2024-2029) & (USD/Unit)
Table 120. Key Raw Materials
Table 121. Raw Materials Key Suppliers
Table 122. Transforming Growth Factor Beta 1 Distributors List
Table 123. Transforming Growth Factor Beta 1 Customers List
Table 124. Transforming Growth Factor Beta 1 Industry Trends
Table 125. Transforming Growth Factor Beta 1 Industry Drivers
Table 126. Transforming Growth Factor Beta 1 Industry Restraints
Table 127. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Transforming Growth Factor Beta 1Product Picture
Figure 5. Global Transforming Growth Factor Beta 1 Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global Transforming Growth Factor Beta 1 Market Size (2018-2029) & (US$ Million)
Figure 7. Global Transforming Growth Factor Beta 1 Sales (2018-2029) & (K Units)
Figure 8. Global Transforming Growth Factor Beta 1 Average Price (USD/Unit) & (2018-2029)
Figure 9. Pirfenidone Product Picture
Figure 10. Galunisertib Product Picture
Figure 11. Others Product Picture
Figure 12. IPF Product Picture
Figure 13. Cancer Product Picture
Figure 14. Others Product Picture
Figure 15. Global Transforming Growth Factor Beta 1 Revenue Share by Manufacturers in 2022
Figure 16. Global Manufacturers of Transforming Growth Factor Beta 1, Manufacturing Sites & Headquarters
Figure 17. Global Manufacturers of Transforming Growth Factor Beta 1, Date of Enter into This Industry
Figure 18. Global Top 5 and 10 Transforming Growth Factor Beta 1 Players Market Share by Revenue in 2022
Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 20. Global Transforming Growth Factor Beta 1 Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. Global Transforming Growth Factor Beta 1 Sales by Region in 2022
Figure 22. Global Transforming Growth Factor Beta 1 Revenue by Region in 2022
Figure 23. North America Transforming Growth Factor Beta 1 Market Size by Country in 2022
Figure 24. North America Transforming Growth Factor Beta 1 Sales Market Share by Country (2018-2029)
Figure 25. North America Transforming Growth Factor Beta 1 Revenue Market Share by Country (2018-2029)
Figure 26. U.S. Transforming Growth Factor Beta 1 Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Canada Transforming Growth Factor Beta 1 Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. Europe Transforming Growth Factor Beta 1 Market Size by Country in 2022
Figure 29. Europe Transforming Growth Factor Beta 1 Sales Market Share by Country (2018-2029)
Figure 30. Europe Transforming Growth Factor Beta 1 Revenue Market Share by Country (2018-2029)
Figure 31. Germany Transforming Growth Factor Beta 1 Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. France Transforming Growth Factor Beta 1 Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. U.K. Transforming Growth Factor Beta 1 Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Italy Transforming Growth Factor Beta 1 Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Russia Transforming Growth Factor Beta 1 Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Asia Pacific Transforming Growth Factor Beta 1 Market Size by Country in 2022
Figure 37. Asia Pacific Transforming Growth Factor Beta 1 Sales Market Share by Country (2018-2029)
Figure 38. Asia Pacific Transforming Growth Factor Beta 1 Revenue Market Share by Country (2018-2029)
Figure 39. China Transforming Growth Factor Beta 1 Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Japan Transforming Growth Factor Beta 1 Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. South Korea Transforming Growth Factor Beta 1 Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. India Transforming Growth Factor Beta 1 Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Australia Transforming Growth Factor Beta 1 Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. China Taiwan Transforming Growth Factor Beta 1 Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Indonesia Transforming Growth Factor Beta 1 Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Thailand Transforming Growth Factor Beta 1 Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Malaysia Transforming Growth Factor Beta 1 Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Latin America Transforming Growth Factor Beta 1 Market Size by Country in 2022
Figure 49. Latin America Transforming Growth Factor Beta 1 Sales Market Share by Country (2018-2029)
Figure 50. Latin America Transforming Growth Factor Beta 1 Revenue Market Share by Country (2018-2029)
Figure 51. Mexico Transforming Growth Factor Beta 1 Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Brazil Transforming Growth Factor Beta 1 Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Argentina Transforming Growth Factor Beta 1 Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Middle East and Africa Transforming Growth Factor Beta 1 Market Size by Country in 2022
Figure 55. Middle East and Africa Transforming Growth Factor Beta 1 Sales Market Share by Country (2018-2029)
Figure 56. Middle East and Africa Transforming Growth Factor Beta 1 Revenue Market Share by Country (2018-2029)
Figure 57. Turkey Transforming Growth Factor Beta 1 Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 58. Saudi Arabia Transforming Growth Factor Beta 1 Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 59. UAE Transforming Growth Factor Beta 1 Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 60. Global Transforming Growth Factor Beta 1 Sales Market Share by Type (2018-2029)
Figure 61. Global Transforming Growth Factor Beta 1 Revenue Market Share by Type (2018-2029)
Figure 62. Global Transforming Growth Factor Beta 1 Price (USD/Unit) by Type (2018-2029)
Figure 63. Global Transforming Growth Factor Beta 1 Sales Market Share by Application (2018-2029)
Figure 64. Global Transforming Growth Factor Beta 1 Revenue Market Share by Application (2018-2029)
Figure 65. Global Transforming Growth Factor Beta 1 Price (USD/Unit) by Application (2018-2029)
Figure 66. Transforming Growth Factor Beta 1 Value Chain
Figure 67. Transforming Growth Factor Beta 1 Production Mode & Process
Figure 68. Direct Comparison with Distribution Share
Figure 69. Distributors Profiles
Figure 70. Transforming Growth Factor Beta 1 Industry Opportunities and Challenges

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings